Intrinsic Value of S&P & Nasdaq Contact Us

Mallinckrodt plc MNKKQ OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • IE • USD

SharesGrow Score
47/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Mallinckrodt plc (MNKKQ) .

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 46/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
47/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
20/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
46/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
85/100
→ Income

Valuation Snapshot — MNKKQ

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$24.14
Book Value / Share$0.00
Revenue / Share$99.98
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%

EPS: Actual vs Estimates

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2014 $-8.47 $2.21B $-717M -32.5%
2017 $18.09 $3.22B $1.77B 55%
2018 $-43.12 $3.22B $-3.62B -112.6%
2019 $-12.00 $3.16B $-1.01B -31.8%
2020 $-11.48 $2.21B $-969.7M -43.8%
2021 $-8.49 $2.21B $-717M -32.5%
2024 $24.14 $1.98B $477.9M 24.1%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message